Sort
130,381 grants matching “hiv”
New analytic approaches and endpoints in human HIV vaccine correlate studies
$792,039Margaret E Ackerman · Dartmouth College · R56 · FY2022 · AI
Studies of Host Cellular Proteins Required for viral Budding and release
$792,018Fadila Bouamr · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Ultra-potent HIV capsid inhibitors
$792,015Mamuka Kvaratskhelia · University Of Colorado Denver · R01 · FY2021 · AI
Ultra-potent HIV capsid inhibitors
$792,015Mamuka Kvaratskhelia · University Of Colorado Denver · R01 · FY2022 · AI
Ultra-potent HIV capsid inhibitors
$792,015Mamuka Kvaratskhelia · University Of Colorado Denver · R01 · FY2024 · AI
Ultra-potent HIV capsid inhibitors
$792,015Mamuka Kvaratskhelia · University Of Colorado Denver · R01 · FY2023 · AI
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine
$792,012Frederick Lewis Altice · Yale University · R01 · FY2021 · DA
Microenterprise and Behavioral Economics Intervention for Sexual and Biomedical HIV Prevention in Vulnerable U.S. Young Adults
$791,988Larissa Jennings Mayo-Wilson · Univ Of North Carolina Chapel Hill · R01 · FY2021 · MD
Biomedical Informatics and Data Science Training at Yale
$791,949Cynthia Ann Brandt · Yale University · T15 · FY2023 · LM
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years
$791,933Joel Palefsky · University Of California, San Francisco · R01 · FY2018 · CA
Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS
$791,912Theodora Hatziioannou · Rockefeller University · R01 · FY2017 · AI
3BNC117 and 10-1074 to suppress HIV-1 replication and reduce the reservoir
$791,861Marina Caskey · Rockefeller University · U01 · FY2019 · AI
Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine
$791,843David J Volsky · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DA
Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine
$791,843David J Volsky · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DA
Unlocking the Potential of HIV-Infected Deceased Donors for Organ Transplantation
$791,824Aaron A Tobian · Johns Hopkins University · R01 · FY2017 · AI
Homeless Youth's Reductions in HIV Risk Acts
$791,820University Of California Los Angeles · R01 · FY2002 · DA
HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapy
$791,766Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2024 · AI
HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapy
$791,766Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2023 · AI
HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapy
$791,766Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2025 · AI
Improving the HIV PrEP Cascade using an Intervention for Healthcare Providers
$791,757Parya Saberi · University Of California, San Francisco · R01 · FY2017 · NR
Target based discovery of next generation pyrazinamide
$791,696Thomas Dick · Hackensack University Medical Center · R01 · FY2022 · AI
Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies
$791,681William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI
Factors associated with Refractory and Early Recurrent Bacterial Vaginosis
$791,678Susan Anne Tuddenham · Johns Hopkins University · R01 · FY2025 · AI
Persistent Immunogenicity of IDLV delivering Gag and membrane tethered HIV-1 Envelope Trimers
$791,661Maria Blasi · Duke University · R01 · FY2025 · AI
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS
$791,611Corinne Elizabeth Augelli-Szafran · Southern Research Institute · R01 · FY2023 · DA